Immunis.AI to Present at the BIO CEO & Investor Conference
ROYAL OAK, Mich.--(BUSINESS WIRE)--#AI--Immunis.AI, a privately held immunogenomics company with a patented liquid biopsy platform, more...
ROYAL OAK, Mich.--(BUSINESS WIRE)--#AI--Immunis.AI, a privately held immunogenomics company with a patented liquid biopsy platform, more...
LONDON--(BUSINESS WIRE)--Rexgenero, a regenerative medicine company pioneering the development of advanced cell-based therapies to treat more...
Data demonstrate potential to increase efficacy of TIL adoptive cell therapy in preclinical models CAMBRIDGE, more...
AlayaCare's acquisition of Arrow Solutions will further enhance and scale its product capabilities in the more...
LONDON--(BUSINESS WIRE)--#CompetitiveIntelligence--A well-known market intelligence company, Infiniti Research, has worked with 100+ companies in the more...
SAN DIEGO & PENNINGTON, N.J.--(BUSINESS WIRE)--OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company more...
AUCKLAND, New Zealand--(BUSINESS WIRE)--#AroaBiosurgery--Aroa Biosurgery, the Auckland-based privately held soft-tissue repair company, has now launched more...
Hiro Capital announces its fourth deal with a Series A lead investment in London-based sports more...
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates more...
SANTA CLARA, Calif.--(BUSINESS WIRE)--$A #Agilent--Agilent Technologies Inc. (NYSE: A) today announced it has reached an more...